Management of Pigmented Conjunctival Lesions

被引:41
作者
Oellers, Patrick [1 ]
Karp, Carol L. [1 ]
机构
[1] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA
关键词
BRAF; complexion-associated melanosis; conjunctival melanosis; genetics; melanoma; nevus; no-touch surgery; ocular surface; pigmented lesion; primary acquired melanosis (PAM); topical chemotherapy; PRIMARY ACQUIRED MELANOSIS; TUMOR-ASSOCIATED LYMPHANGIOGENESIS; TOPICAL MITOMYCIN-C; MALIGNANT-MELANOMA; MELANOCYTIC LESIONS; PROGNOSTIC-SIGNIFICANCE; CONSECUTIVE PATIENTS; CUTANEOUS MELANOMA; UVEAL MELANOMA; UNITED-STATES;
D O I
10.1016/j.jtos.2012.08.002
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Pigmented conjunctival lesions primarily include melanoma, nevus, primary acquired melanosis (PAM), and complexion-associated melanosis. The incidence of conjunctival malignant melanoma (CMM) has significantly increased in the USA and Europe over the years, and it carries a very serious risk for metastasis and melanoma-related death. Conjunctival melanoma can arise de novo or from precursor lesions, nevus, and PAM. PAM is histologically separated into two distinct forms: PAM with atypia and without atypia. PAM with severe atypia progresses to malignant melanoma in up to 50% of cases and PAM without atypia virtually never progresses. Nevus is a benign melanocytic tumor that only rarely undergoes malignant transformation. Complexion-associated melanosis is frequently seen in more darkly pigmented individuals and does not progress to melanoma, although it can become very large. A detailed literature review on the various pigmented conjunctival lesions together with a schematic approach to diagnosis and management is presented.
引用
收藏
页码:251 / 263
页数:13
相关论文
共 69 条
[31]  
Kim JW, 2008, CLIN OPHTHALMOL, V2, P503
[32]   Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma [J].
Kurli, M. ;
Chin, K. ;
Finger, P. T. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (04) :479-482
[33]   Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience [J].
Kurli, M ;
Finger, PT .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 243 (11) :1108-1114
[34]   Conjunctival Nevi Clinical Features and Therapeutic Outcomes [J].
Levecq, Laurent ;
De Potter, Patrick ;
Jamart, Jacques .
OPHTHALMOLOGY, 2010, 117 (01) :35-40
[35]   Limbal Stem Cell Deficiency after Topical Mitomycin C Therapy for Primary Acquired Melanosis with Atypia [J].
Lichtinger, Alejandro ;
Pe'er, Jacob ;
Frucht-Pery, Joseph ;
Solomon, Abraham .
OPHTHALMOLOGY, 2010, 117 (03) :431-437
[36]   Malignant conjunctival melanoma - Clinical review with recommendations for diagnosis, therapy and follow-up [J].
Lommatzsch, PK ;
Werschnik, C .
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2002, 219 (10) :710-721
[37]   Intraocular invasion of a conjunctival melanoma [J].
Lommatzsch, PK ;
Werschnik, C ;
Gütz, U .
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1999, 215 (06) :370-372
[38]  
McLean I W, 1998, Ann Diagn Pathol, V2, P264, DOI 10.1016/S1092-9134(98)80016-6
[39]   Conjunctival melanoma in the Netherlands: A nationwide study [J].
Missotten, GS ;
Keijser, S ;
De Keizer, RJW ;
De Wolff-Rouendaal, D .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (01) :75-82
[40]  
Oellers P, 2011, TECH OPHTHALMOL, V9, P5762